EPCAM and neoplasm: Cancer stem cells expressing EpCAM are more tumorigenic than EpCAM-negative stem cells[11,26] and, due to their resistance to radiation and chemotherapy, targeting EpCAM might be a promising approach to impede tumor recurrence after chemo- or radiotherapy.